$51.30
-2.91-5.37%
最終更新: Oct 15, 4:00 PM
$54.21
N/A
Benzinga
Benzinga
Benzinga
日曜日, 10 18
Benzinga
© 2026 Benzinga | All Rights Reserved
Bright Minds Biosciences (DRUG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.39 | $-1.39 | $-1.39 | $-1.34 |
| Actual | $-0.17 | $-1.09 | $-0.79 | $-0.97 |
| Surprise | +87.8% | +21.6% | +43.2% | +27.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q3 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-1.09 | $-1.31 | $-1.33 |
| Revenue | |||
| Consensus | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q3 | Aug 17, 2026 | $-0.17 | $-1.39 | 87.8 % |
| Q2 | May 20, 2026 | $-1.09 | $-1.39 | 21.6 % |
| Q1 | May 19, 2026 | $-0.79 | $-1.39 | 43.2 % |
| Q4 | Feb 13, 2026 | $-0.97 | $-1.34 | 27.6 % |